GBT440-039 A Phase 4, Multicenter, Open-label Study to Evaluate the Treatment Effect of Voxelotor on Physical Activity in Adolescents and Adults with Sickle Cell Disease
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
August 26, 2020
End Date
August 31, 2023
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
August 26, 2020
End Date
August 31, 2023